Opportunity for Iopofosine Expansion Within Areas of High Unmet Need in Non-Hodgkin’s Lymphoma Establishes Partnership With One of the Largest Cancer Research and Treatment Organizations in the U.S.

“The present studies were performed to extend our knowledge of GZ17-6.02 biology from that known in solid tumor cell types such as prostate cancer cells to liquid tumor cell types, for example, ...

Mycosis fungoides was the first type of lymphoma to be treated with radiation (Scholz, 1902). Since its use in the early 1900s, technical advances have led to the development of electron beam ...

Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma. It is characterized by malignant T-cell lymphocytes in the skin. It presents as patch, plaque, or tumor stage and is often ...

First English-language case study shows resolution of lesions with 308-nm Excimer laser in rare mycosis fungoides (MF) subtype, poikilodermatous mycosis fungiodes (pMF), underscoring the Company’s ...

Pharmaceutical and biotechnology companies are intensifying their focus on research areas to address the unmet needs of highly effective treatments for folliculotropic mycosis fungoides. Concurrently, ...